This announcement is a separate document:
四環醫藥：自願公告 - 惠升生物研發的司美格魯肽注射液獲批開展臨床實驗
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - HUISHENG BIOPHARMACEUTICAL''S DRUG SEMAGLUTIDE INJECTION OBTAINED APPROVAL FOR CLINICAL TRIAL
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.